Oramed Pharmaceuticals CEO Nadav Kidron's 2018 pay jumps 34% to $1.6M
Oramed Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: August 6, 2019
Oramed Pharmaceuticals reported fiscal year 2018 executive compensation information on August 6, 2019.
In 2018, three executives at Oramed Pharmaceuticals received on average a compensation package of $881.6K, a 15% decrease compared to previous year.
Nadav Kidron, Chief Executive Officer, received $1.6M in total, which increased by 34% compared to 2017. 33.71% of Kidron's compensation, or $522.6K, was in option awards. Kidron also received $148.8K in bonus, $436.3K in salary, as well as $442.3K in other compensation.
Miriam Kidron, Chief Scientific Officer, received a compensation package of $587.1K, which decreased by 53% compared to previous year. 46.60% of the compensation package, or $273.6K, was in salary.
Joshua Hexter, Chief Operating Officer, earned $507.6K in 2018, a 27% decrease compared to previous year.
Oramed Pharmaceuticals' fiscal year ends on August 31.